𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bioavailability and pharmacokinetics of β- methyldigoxin after multiple oral and intravenous doses

✍ Scribed by N. Rietbrock; J. Guggenmos; J. Kuhlmann; U. Hess

Publisher
Springer
Year
1976
Tongue
English
Weight
764 KB
Volume
9
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of deramciclane in dogs
Pharmacokinetics of deramciclane in dogs after single oral and intravenous dosing and multiple oral dosing
✍ Harri Kanerva; Hannele Huuskonen; Anneli Alhonen-Raatesalmi; Timo Nevalainen; Ar 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 2 views

The pharmacokinetics of a new serotonin 5-HT 2 antagonist, deramciclane, was studied. Single oral doses of 1, 3, 6 and 10 mg kg -1 and intravenous doses of 1, 3 and 6 mg kg -1 were administered in beagle dogs. Moreover, the steady state pharmacokinetics of 1, 3 and 6 mg kg -1 doses were studied. Der

Phenylpropanolamine pharmacokinetics in
Phenylpropanolamine pharmacokinetics in dogs after intravenous, oral, and oral controlled-release doses
✍ Munir A. Hussain; Bruce J. Aungst; Gilbert Lam; Eli Shefter 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB 👁 2 views

An adaption of a published high performance liquid chromatographic (HPLC) assay for phenylpropanolamine (PPA) in plasma was used to examine PPA pharmacokinetics in dogs. Plasma was extracted into ethyl acetate after the addition of 3.5 per cent sodium carbonate, and was then back-extracted into aque

Pharmacokinetics of tamoxifen after intr
Pharmacokinetics of tamoxifen after intravenous and oral dosing of tamoxifen–hydroxybutenyl-β-cyclodextrin formulations
✍ Buchanan, Charles M. (author);Buchanan, Norma L. (author);Edgar, Kevin J. (autho 📂 Article 📅 2007 🏛 John Wiley and Sons Inc. 🌐 English ⚖ 364 KB

Oral and intravenous administration of tamoxifen base and tamoxifen citrate formulated with hydroxybutenyl-beta-cyclodextrin (HBenBCD) to Sprague-Dawley rats significantly increased the oral bioavailability of tamoxifen relative to that of parent drug (no HBenBCD). When formulated with HBenBCD, the

Pharmacokinetics of benzydamine after in
Pharmacokinetics of benzydamine after intravenous, oral, and topical doses to human subjects
✍ G. A. Baldock; R. R. Brodie; L. F. Chasseaud; T. Taylor; L. M. Walmsley; B. Cata 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 540 KB

## Abstract The pharmacokinetics of the anti‐inflammatory drug benzydamine were determined after intravenous infusion of 5 mg to six healthy male subjects. Benzydamine was characterized as a drug of relatively low systemic clearance (ca. 160 ml min^−1^) but high volume of distribution (ca. 1101); t

Pharmacokinetics of two lorazepam formul
Pharmacokinetics of two lorazepam formulations, oral and sublingual, after multiple doses
✍ G. Caillé; J. Spénard; Y. Lacasse; J. Brennan 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 484 KB

The pharmacokinetic profiles of a sublingual and a conventional oral lorazepam tablet formulation were established following chronic administration to twelve healthy male volunteers. Fitting a multi-dose equation based on a one-compartment model to the observed data, the average elimination half-liv